• About
  • Masthead
  • License Content
  • Advertise
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Endocrinology

Ultrasound useful for risk stratification after nondiagnostic thyroid biopsy

byXiaofan PanandAaron Maxwell, MD
August 24, 2014
in Endocrinology, Imaging and Intervention, Oncology
Reading Time: 2 mins read
Three ultrasonographic findings portend increased risk of malignancy in thyroid nodules
Share on FacebookShare on TwitterShare on LinkedIn

1. Among patients with a nondiagnostic fine needle aspiration biopsy (FNAB) of thyroid nodules, the use of an ultrasound-based evaluation tool appropriately stratified patients according to malignancy risk. 

2. Results suggest that thyroid nodules with two or more suspicious ultrasound features should undergo repeat FNAB, while those with fewer than two suspicious features can be followed with ultrasound. 

Evidence Rating Level: 3 (Average)        

Study Rundown: Evaluation of patients with thyroid nodules typically includes FNAB, an approach critical for the detection of cancer. Although the majority of biopsies are adequate for a cytological diagnosis, up to 21% will be nondiagnostic. These biopsies represent a significant problem, and the management of thyroid nodules in which FNAB is nondiagnostic remains controversial. This study examined the usefulness of repeat FNAB in detecting malignancy in nondiagnostic thyroid nodules in relation to the thyroid imaging reporting and data system (TIRADS), a classification scheme for malignancy risk based on abnormalities and suspicious features detected via ultrasound. Nondiagnostic thyroid nodules were evaluated retrospectively according to TIRADS, and malignancy risk was calculated for nodules in each TIRADS categories. Results of the investigation suggest that TIRADS can appropriately stratify patients according to their risk of thyroid malignancy. Based on this, the authors suggested that for nodules with fewer than two suspicious features can be followed with ultrasound, while those with two or more may benefit from repeat FNAB. This study is limited in its retrospective nature, which may have introduced selection bias when considering how nodules were categorized in the analysis. Additionally, the number of nodules across each TIRADS category varied, which may have impacted the significance of the findings.

Click to read the study in Radiology

Relevant Reading: Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk

RELATED REPORTS

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

Transcranial ultrasound stimulation may modulate acute heat pain perception

In-Depth [retrospective cohort]: The medical records of 530 patients (430 women, 100 men) with nondiagnostic thyroid FNABs were retrospectively reviewed, with a total cohort of 548 nodules (7.3% malignant, 92.7% benign). Malignancy risk for the nodules was stratified into TIRAD categories based on suspicious ultrasonography findings such as hyper- and hypo- echogenicity, atypical internal variation, calcifications, irregular margins and abnormal shape. The malignancy risks of categories 3 and 4a nodules were 0.8% and 1.8%, respectively, while malignancy risks for higher TIRADS categories of 4b, 4c, and 5 nodules were 6.1%, 14.4%, and 31%. Researchers in this study also classified nodules according to size (294 larger than 10mm, 254 10mm or smaller). Among nodules >10mm, the malignancy risks of categories 3, 4a, 4b, 4c, and 5 nodules were 0.9%, 1.3%, 0%, 15%, and 33%, respectively. Among nodules ≤10 mm, the malignancy risks of categories 3, 4a 4b, 4c, and 5 nodules were 0%, 2.7%, 14%, 14.3%, and 31%.

More from this author: Mammography linked to improved breast cancer outcomes among women 75 and older

Image: CC/Wiki

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: thyroid cancerultrasound
Previous Post

Association of obesity and dementia varies with age

Next Post

Suicide tourism increases in Switzerland

RelatedReports

An illustration depicting a needle approaching electrodes placed near key anatomical structures, suggesting a procedure for pain relief.
Chronic Disease

An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain

September 17, 2026
Brain lesions on MRI linked with subsequent increased stroke risk
Imaging and Intervention

Transcranial ultrasound stimulation may modulate acute heat pain perception

April 20, 2026
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Chronic Disease

An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index

February 6, 2026
Many new pediatric asthma cases attributable to obesity
Chronic Disease

GLP-1 receptor agonists show little effect on obesity-related cancer risk

December 8, 2025
Next Post
Suicide tourism increases in Switzerland

Suicide tourism increases in Switzerland

High cumulative-dose isotretinoin treatment decreases risk of acne relapse

Severe acne linked to endometriosis

Patients with late stage melanoma remain at risk for further primary melanoma

Key characteristics of high mitotic rate melanoma elucidated

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind October 19, 2026
  • Deep learning model demonstrates potential to generate an interpretable brain health biomarker from sleep electroencephalography
  • Low-pressure pneumoperitoneum does not reduce pain after laporoscopic cholecystectomy
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.